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ABSTRAK
Tujuan: untuk mempelajari korelasi anti-NS-1 dan anti-PDI dengan hambatan fungsi agregasi trombosit pada 
infeksi dengue sekunder. Metode: penelitian ini dilakukan dengan desain potong lintang pada 50 pasien dengue 
sekunder. Dilakukan pengukuran hambatan fungsi agregasi trombosit serial sampel serum pasien pada hari demam 
ketiga, lima dan tujuh. Juga dilakukan deteksi anti-NS-1 dan anti-PDI pada sampel yang sama menggunakan 
metode solid phase ELISA. Hasil: terdapat penghambatan agregasi trombosit yang semakin meningkat antar hari 
pemeriksaan. Terdapat perbedaan bermakna nilai hambatan agregasi antar hari pemeriksaan (p<0,05). Tidak 
didapatkan penghambatan agregasi trombosit bila dikelompokkan berdasarkan jumlah trombosit >100.000/uL 
atau <100.000/uL. Anti-NS-1 dan anti-PDI terdeteksi mulai hari ketiga. Dari 50 pasien didapatkan 90% positif 
IgG anti-NS-1 dan 72% positif IgG anti-PDI. Kinetika kadar anti NS1 yang dinyatakan dengan OD, tertinggi 
pada hari ketiga dan mengalami penurunan pada hari ketujuh. Kinetika anti-PDI pada umumnya mengalami 
peningkatan dari hari ketiga demam sampai hari ketujuh. Terdapat korelasi bermakna (r=0,386-0,490) antara 
OD anti-NS-1 dan OD anti-PDI, sedangkan perbedaan OD antar hari pemeriksaan tidak bermakna (p>0,05). 
Kesimpulan: anti-NS-1 dan anti-PDI pada infeksi dengue sekunder terdeteksi sejak hari ketiga demam. Terdapat 
hambatan agregasi trombosit pada pasien dengue sekunder. Anti-NS-1 dan anti-PDI kemungkinan berperan pada 
hambatan fungsi agregasi trombosit tetapi secara stastistik tidak menunjukkan korelasi bermakna. Mungkin ada 
mekanisme lain yang turut berperan pada hambatan agregasi trombosit.
Kata kunci: anti NS-1, anti PDI, hambatan agregasi trombosit, infeksi dengue sekunder.
ABSTRACT
Aim: to observe the correlation between anti-NS-1 and anti PDI antibodies against platelets function 
disorder on secondary dengue infection. Methods: 50 patients with secondary DV infection according to WHO 
criteria were observed by a cross sectional study. Patient’s blood was collected on day 3, 5 and 7 after fever 
onset. Platelets aggregation test was done to prove the possibility of platelets dysfunction. Anti-NS-1 and anti-
PDI antibodies were determined by solid phase ELISA. Results: the inhibition of platelets aggregation was 
increased among day of observation. Means value of inhibition on day 3 is 46.6%, day 5 is 52.5% and day 7 
is 56%. There is a significant difference (p<0.05) of inhibition of platelet aggregation value between days of 
observation. The antibodies against NS-1 DV and PDI were detected in all 50 sera with the positive rate of 90% 
develop NS-1 antibodies and 72% of PDI antibodies, on day 3 of symptoms. The highest OD of NS-1 antibodies 
is detected on the day 3 and decreased on day 7. The OD of PDI antibodies was increased on day 3 and still 
increasing on day 7. There is a significant correlation between anti NS-1 and PDI antibodies (r=0.386-0.490), 
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while the differences of OD between observation days are not significant (p>0.05). Conclusion: the kinetics 
profile of NS1 and PDI antibodies responses, which were detected by the third day of symptoms. Dengue patients’ 
sera inhibited platelets aggregation. NS-1 antibodies and PDI antibodies might have a role on the platelets 
aggregation dysfunction; however, there is no correlation between them. It is possible that other mechanism 
involve in the inhibition of platelets aggregation.
Key words: anti-NS-1 antibodies, anti PDI antibodies, inhibition platelets aggregation, secondary dengue 
infection.
INTRODUCTION
Dengue infection is one of the major public 
health problems in Indonesia.1 The incidence rate 
of the disease increased rapidly during the last 
decades. Dengue virus (DV) consist of four distinct 
serotypes (DENV 1 to 4).2,3 Infection with any one 
of the serotypes can caused a broad spectrum of 
manifestations from asymptomatic or mild dengue 
fever (DF) to dengue shock syndrome (DSS).4-5 
Hemorrhagic syndrome, a feature of DHF/DSS, 
is a hematologic abnormality resulting from 
multiple factors, including thrombocytopenia, 
coagulopathy and vasculopathy related with 
dysfunction of platelets and endothelial cells.6-7 
However, the mechanisms underlying severe 
bleeding in dengue DHF are not completely 
understood.8 Recently, Falconar et al. proposed 
that the dengue virus nonstructural-1 protein (DV 
NS1) generated antibodies to common epitopes 
on human blood clotting and integrin/adhesion 
proteins present on the platelets.9
The findings of transient thrombocytopenia 
associated with the generation of antiplatelet 
antibodies like anti-NS-1 antibodies in dengue 
virus infected in mice further support the hypothesis 
that cross-reactive anti-NS-1 antibodies may play a 
role in dengue pathogenesis.10-12 Furthermore, anti-
NS-1 mediated platelet aggregation inhibition, 
is at least in part, attributable to its binding and 
inhibitory effect on Protein disulfide Isomerase 
(PDI).13 However the mechanism of anti-DV 
NS-1 mediated inhibition of platelet aggregation 
remains unclear.14 In this study, we observed 
the correlation between anti-NS-1 and anti-PDI 




The study wes held at Biology Molecular 
Laboratory of Hematology and Medical Oncology 
Division of the Department of Internal Medicine 
of Cipto Mangunkusumo National Central 
General Hospital and Faculty of Medicine 
University of Indonesia from March 2011 to 
April 2012.
Serum samples were obtained from 50 patients 
that hospitalized at the Cipto Mangunkusumo 
Hospital and Kramat 128 hospital Jakarta. The 
criteria of inclusion are as follows: patient 
with sudden fever at least three days who were 
classified as having dengue haemorrhagic fever 
according to the WHO criteria (WHO 1997), 
anti-NS-1 positive, anti-dengue IgG positive 
and agree to sign an informed consent form. The 
exclusion criteria included mix infection with 
another infection illness, liver function disorder, 
got steroid treatment and patients disagree to 
participated in this study.
The serum samples were collected from 
confirmed cases of dengue virus infected patients 
on day 3, 5 and 7 after fever (n=50, total 150). NS1 
detection was measured with the commercially 
available pan bio dengue early ELISA (Cat 
No. E-DEN01P) and anti-dengue IgM and IgG 
antibodies were measured with the commercially 
available AIM dengue triple line rapid test®.
Antigen and Reagents
Dengue virus NS-1 glycoprotein (ab64456, 
Abcam,UK). PDI protein (ab31810, Abcam, 
UK). Horseradish peroxidase (HRP)-conjugated 
Goat anti human IgG Fc from Jackson 
Immunoresearch Lab (West Grove,PA,USA). 
Non-fat dry milk (NFDM) (Zygma). Substrate 
3.3’, 5.5’-tetramethylbenzidine (TMB) from 
invitrogen. Agonist adenosin diphosphat (ADP) 
from Helena platelet aggregation reagents 
(Helena laboratories).
Analysis of ADP–stimulated Inhibition Platelet 
Aggregation
Human whole blood was mixed with 0,11 M 
sodium citrate (9:1) and centrifuged at 100 x g 
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for 10 min at room temperature. The upper layer 
was collected as platelet rich plasma (PRP). The 
lower layer was subsequently centrifuged at 1000 
x g for 10 min and the supernatant was collected 
as platelet poor plasma (PPP). The PPP was used 
as blank for analysis of platelet aggregation. The 
PRP was incubated with 5 µL of DF/DHF patient 
sera mixture at 370C for 30 min, followed by 
addition of ADP (10 µM final concentration). 
Inhibition platelet aggregation was detected using 
an automated aggregometer (Helena AggRam™). 
Determination of Anti-NS-1 Antibodies and 
Anti-PDI Antibodies by Solid Phase ELISA
According against NS-1 antigen in patient 
sera was analyzed by the solid phase ELISA, 
according to Alcon et al8, Shu et al9 and Cheng 
et al.6 Microtiter wells (NUNC, Denmark) were 
coated with 50 µL of recombinant Dengue Virus 
NS1 glycoprotein (5 µg/mL) or 50 µL PDI 
protein (5 µg/mL) in 0,1 M bicarbonate buffer 
pH 9,5, incubate 40C overnight. After blocking 
with 5% skim in phosphate–buffered saline 
(PBS), diluted serum sample (1:50 in blocking 
buffer) was added and incubated overnight 
at 40C. Wells were washed 5 times with 200 
µL PBS 0.1% Tween 20 (PBST). 100 uL of 
horseradish peroxidase labeled goat anti-human 
IgG (1:15.000 dilution) was added for 1 h at 370C. 
The preparations were then washed and incubated 
with 3,3’5,5’-tetramethylbenzidine (TMB). The 
enzyme activity was developed; absorbance was 
measured using infinite f 200 TECAN Reader 
(Austria) at 450 nm. Serum samples from healthy 
donors were used as control negative (n=5). 
Positivity was determined by comparison to 
individual negative controls. A positive sample 
was defined as having a test absorbance/negative 
control ratio of ≥2.0 and a negative sample was 
defined as having a ratio of ≤2.0.
Statistical Analysis
We used the Pearson correlation test to 
examine correlation between anti-NS-1 and 
anti-PDI with platelet aggregation. p<0.05 was 
considered significant. The related ANOVA for 
comparison between normally distributed OD 
anti NS1, OD anti-PDI and platelet aggregation 
and Friedman test was used if data are not 
normally distributed. For all statistical analysis, 
we used the SPSS version 17.0 software 
package.
RESULTS
In this study we analyzed 150 serum samples 
from 50 patients with laboratory confirmation 
of inhibition platelet aggregation, IgG NS1 
antibodies and IgG PDI antibodies. All of these 
patients were classified as secondary infection 
based on interpretative criteria described above. 
Dengue Patient Sera Inhibit ADP–induced 
Platelet Aggregation
The platelet functional assay was also carried 
out and results showed that the patient serum 
caused an inhibition on platelet aggregation 
induced by ADP (Figure 1). The inhibitions 
of platelets aggregation were increased among 
day of observation. Means value of inhibition 
on day 3 is 46.6%, day 5 is 52.2% and day 7 is 
56%. There is a significant difference (p<0.05) of 
inhibition of platelet aggregation value between 
days of observation (Anti-NS-1 antibodies and 
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Figure 1. Kinetics of inhibition platelet aggregation in DV 
secondary infection
The presence of anti NS1 antibodies and 
anti PDI antibodies in the serum of patients with 
secondary infection was analyzed using solid 
phase ELISA. The antibodies against NS-1 DV 
and PDI were detected in all 50 patients with the 
positive rate of 90% develop NS-1 antibodies and 
72% of PDI antibodies, on day 3 of symptoms. 
The highest OD of NS-1 antibodies is detected 
on the day 3 and decreased on day 7. The OD of 
PDI antibodies was increased on day 3 and still 
increasing on day 7. (Figure 2)
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There is a weak correlation between anti 
NS-1 antibodies and the inhibition of platelets 
aggregation (r=0.160, p=0.267), and also 
between anti PDI antibodies and the inhibition of 
platelets aggregation (r=-0.081, p=0.578).
There is a significant correlation between 
anti-NS-1 and PDI antibodies (r=0.386-0.490, 
p<0.01), while the differences of OD between 
observation days are not significant (p>0.05). 
Figure 3.
of platelet and endothelial cells.10 Although the 
exact pathomechanism is not very well defined, 
available data strongly suggest that in the most 
cases of DHF immune mediated mechanism 
play also an important role in the destruction of 
platelets and disturbance of endothelial function.2
Several evidences indicated a mechanism of 
molecular mimicry in which antibodies against 
non structural protein NS1 of DENV (anti-NS-1 
antibodies) can also cross react with platelet and 
endothelial cells, thereby may induce platelet 
destruction and endothelial disturbance in DHF 
patients.10
Recent study reported by Cheng et al. 
demonstrated that anti-NS-1 antibodies 
recognized PDI on platelet surface causing 
inhibition of platelet aggregation induced by 
ADP.6 Further analysis showed that anti NS1 
antibodies bound to amino acid residues 311-
330 of DENV NS1, which shares sequence 
homology with the thioredoxin domain of PDI.6 
Interestingly, PDI has been to play a role on the 
regulation of integrin activation showed that 
modulation of the thiol isomerase activity of 
PDI by divalent manganese cation leads to PDI.7
In this study, the presence of antibodies 
directed against platelets was demonstrated in 
dengue patient sera, which revealed the inhibitory 
effect on platelet aggregation by DF/DHF patient 
sera.
CONCLUSION
This study shows the kinetics profile of 
NS-1 and PDI antibodies responses, which were 
detected by the third day of symptoms. Dengue 
patient’s sera also inhibited platelets aggregation. 
NS-1 antibodies and PDI antibodies might have 
a role on the platelets aggregation dysfunction, 
but statistically there is no correlation between 
them. It is possible that other mechanism involve 
in the inhibition of platelets aggregation.
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Figure 2. Kinetics of IgG NS1 antibodies and IgG PDI 
antibodies in DV secondary infection
Figure 3. The correlation between anti-PDI antibodies and 
anti-NS-1 antibodies  in day 3, 5 and 7 fever (r=0,490; p=0,001)
DISCUSSION
DHF is the main cause mortality in dengue 
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feature of DHF is a hematologic abnormality 
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